help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Møller, A. M.
Right arrow Articles by Pedersen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Møller, A. M.
Right arrow Articles by Pedersen, O.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 1 367-369
Copyright © 1999 by The Endocrine Society


Original Studies

A Novel Phe75fsdelT Mutation in the Hepatocyte Nuclear Factor-4{alpha} Gene in a Danish Pedigree with Maturity-Onset Diabetes of the Young1

Ann M. Møller, Louise T. Dalgaard, Louise Ambye, Lars Hansen, Ole Schmitz, Torben Hansen and Oluf Pedersen

Steno Diabetes Center and Hagedorn Research Institute (A.M.M., L.T.D., L.A., L.H., T.H., O.P.), Gentofte, Copenhagen DK-2820, Denmark; and Department of Medicine M (Endocrinology and Diabetes) (O.S.), Kommunehospitalet, University Hospital of Aarhus, Aarhus D12-8000, Denmark

Address all correspondence and requests for reprints to: Ann Merete Møller, M.S., Steno Diabetes Center, Niels Steensens Vej 2, DK- 2820 Gentofte, Copenhagen, Denmark.

Mutations in 5 different genes [the hepatocyte nuclear factor (HNF)-4{alpha}), glucokinase, HNF-1{alpha}, insulin promoter factor-1, and HNF-1ß genes] have been shown to cause maturity onset diabetes of the young (MODY). About 50% of all known MODY in Danish Caucasian MODY probands can be explained by mutations in the HNF-1{alpha} gene (MODY3). To estimate the prevalence of MODY caused by mutations in the HNF-4{alpha} gene (MODY1), we screened 10 non-MODY3 probands for mutations in the minimal promoter and the 12 exons of the HNF-4{alpha} gene. One of the probands had a novel frameshift mutation (Phe75fsdelT) in exon 2 of the HNF-4{alpha} gene, resulting in a premature termination of translation after 117 amino acids of the messenger RNA encoded by that allele. The mutation cosegregated with diabetes in the pedigree and was not detected in 84 unrelated Danish Caucasian healthy glucose-tolerant control subjects or in 84 type 2 diabetic patients. At the time of examination, 4 of 6 mutation carriers were treated with insulin and 2 with oral hypoglycemic medication. Two mutation carriers had late-diabetic complications. Even though the HNF-4{alpha} protein is known to be important in the regulation of genes involved in lipid metabolism, carriers of the mutation did not differ from age and sex-matched control subjects, in regard to levels of fasting serum total cholesterol, serum high-density lipoprotein-cholesterol, and serum triglyceride. In conclusion, by screening 10 non-MODY3 probands for mutations in the HNF-4{alpha} gene, we identified 1 diabetes-associated frameshift mutation (Phe75fsdelT), suggesting that defects in HNF-4{alpha} are a rare cause of MODY in Denmark.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Johansen, J. Ek, H. B. Mortensen, O. Pedersen, and T. Hansen
Half of Clinically Defined Maturity-Onset Diabetes of the Young Patients in Denmark Do Not Have Mutations in HNF4A, GCK, and TCF1
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4607 - 4614.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Ek, C. S. Rose, D. P. Jensen, C. Glumer, K. Borch-Johnsen, T. Jorgensen, O. Pedersen, and T. Hansen
The Functional Thr130Ile and Val255Met Polymorphisms of the Hepatocyte Nuclear Factor-4{alpha} (HNF4A): Gene Associations with Type 2 Diabetes or Altered {beta}-Cell Function among Danes
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3054 - 3059.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Bartoov-Shifman, R. Hertz, H. Wang, C. B. Wollheim, J. Bar-Tana, and M. D. Walker
Activation of the Insulin Gene Promoter through a Direct Effect of Hepatocyte Nuclear Factor 4alpha
J. Biol. Chem., July 12, 2002; 277(29): 25914 - 25919.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Barrio, C. Bellanne-Chantelot, J. C. Moreno, V. Morel, H. Calle, M. Alonso, and C. Mustieles
Nine Novel Mutations in Maturity-Onset Diabetes of the Young (MODY) Candidate Genes in 22 Spanish Families
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2532 - 2539.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Lausen, H. Thomas, I. Lemm, M. Bulman, M. Borgschulze, A. Lingott, A. T. Hattersley, and G. U. Ryffel
Naturally occurring mutations in the human HNF4{alpha} gene impair the function of the transcription factor to a varying degree
Nucleic Acids Res., January 15, 2000; 28(2): 430 - 437.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society